NNCSF (Nanosonics) Stock Based Compensation: $0.0 Mil (TTM As of Dec. 2025)


NNCSF Nanosonics Ltd NNCSF
90 GF Score
Price $2.55
GF Value $3.56
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nanosonics Stock Based Compensation?

Nanosonics NNCSF 90 Stock Based Compensation is $0.0 Mil as of Dec. 2025. GuruFocus rates NNCSF with a GF Score™ of 90/100 and a GF Value™ of $3.56 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Nanosonics's Stock Based Compensation for the six months ended in Dec. 2025 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Nanosonics Stock Based Compensation Related Terms

Nanosonics Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Nanosonics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosonics Stock Based Compensation Chart

Nanosonics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nanosonics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NNCSF
90GF Score
Nanosonics Ltd NNCSF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanosonics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

What does a Stock Based Compensation of $0.0 Mil mean?
Nanosonics (NNCSF) has a Stock Based Compensation of $0.0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Nanosonics and its competitors.
Is Nanosonics' Stock Based Compensation too high?
Nanosonics' current Stock Based Compensation is $0.0 Mil. Overall, Nanosonics has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanosonics' Stock Based Compensation compare to ISRG and BDX?
Nanosonics' Stock Based Compensation of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Nanosonics and its competitors. Nanosonics's current Stock Based Compensation is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosonics stock overvalued right now?
Based on GuruFocus' analysis, Nanosonics (NNCSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.56, compared to a current price of $2.55 — trading 28.4% below its estimated fair value. The current Stock Based Compensation is $0.0 Mil. Nanosonics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Nanosonics (NNCSF), the current Stock Based Compensation is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanosonics (NNCSF) Overvalued in 2026?

Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued. The current stock price of $2.55 is trading 28.4% below its estimated GF Value™ of $3.56. GuruFocus considers Nanosonics to be Modestly Undervalued.

Key valuation signals for NNCSF:

  • Stock Based Compensation: $0.0 Mil
  • GF Value™: $3.56 vs. price of $2.55 (28.4% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the NNCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanosonics Business Description

Other Exchanges NAN:Australia
Address 7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
90GF Score

Get the complete analysis for NNCSF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.55
Price
$3.56
GF Value